Table 3 |
||||
|
Hazard ratio of developing hyperuricemia* in African-Americans compared to whites, stratified by sex |
||||
|
Men |
Women |
|||
|
|
||||
|
Hazard ratio |
95% Confidence interval |
Hazard ratio |
95% confidence interval |
|
|
Age-adjusted |
0.87 |
0.73 to 1.04 |
2.79 |
2.02 to 3.86 |
|
Model 1 † |
1.14 |
0.95 to 1.36 |
2.36 |
1.67 to 3.35 |
|
Model 2 ‡ |
0.94 |
0.75 to 1.17 |
1.92 |
1.23 to 3.00 |
|
Model 3 § |
Not applicable |
1.94 |
1.14 to 3.29 |
|
|
Model 4 || |
1.12 |
0.88 to 1.40 |
2.31 |
1.34 to 3.99 |
|
|
||||
|
*Defined as the finding of a serum urate of 6.8 mg/deciliter or higher at any follow-up visit (years 10, 15, or 20). † Adjusted for age at enrollment, baseline body-mass index, glomerular filtration rate, presence of hypertension, use of diuretics, and use of other antihypertensive medication. ‡ Adjusted for variables described for model 1 plus baseline intakes of beer, wine, liquor, meat, seafood, dairy, total protein. § Adjusted for variables described in model 2 plus onset of menopause by then end of follow-up. || Adjusted for variable described in model 2 (men) and model 3 (women) plus baseline serum urate levels |
||||
|
Gaffo et al. Arthritis Research & Therapy 2012 14:R4 doi:10.1186/ar3552 |
||||